An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer
出版年份 2018 全文链接
标题
An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer
作者
关键词
Urinary biomarker, Test, Follow-up, Surveillance, Non-muscle invasive bladder cancer, Recurrence
出版物
WORLD JOURNAL OF UROLOGY
Volume -, Issue -, Pages -
出版商
Springer Nature
发表日期
2018-06-21
DOI
10.1007/s00345-018-2380-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter Study
- (2018) Siamak Daneshmand et al. JOURNAL OF UROLOGY
- Evolution of technologies in urology: full steam ahead?
- (2018) Nathan Lawrentschuk WORLD JOURNAL OF UROLOGY
- EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
- (2017) Marko Babjuk et al. EUROPEAN UROLOGY
- Urinary UBC Rapid and NMP22 Test for Bladder Cancer Surveillance in Comparison to Urinary Cytology: Results from a Prospective Single-Center Study
- (2017) Renate Pichler et al. International Journal of Medical Sciences
- Performance Characteristics of a Multigene Urine Biomarker Test for Monitoring for Recurrent Urothelial Carcinoma in a Multicenter Study
- (2017) Laimonis Kavalieris et al. JOURNAL OF UROLOGY
- FGFR3 , TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study
- (2017) Willemien Beukers et al. JOURNAL OF UROLOGY
- Predictive role of serum and urinary cytokines in invasion and recurrence of bladder cancer
- (2017) Nitu Kumari et al. TUMOR BIOLOGY
- Clinical comparison of noninvasive urine tests for ruling out recurrent urothelial carcinoma
- (2017) Yair Lotan et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer
- (2016) Jean-Pierre Roperch et al. BMC CANCER
- Cytokine Panel for Response to Intravesical Therapy (CyPRIT): Nomogram of Changes in Urinary Cytokine Levels Predicts Patient Response to Bacillus Calmette-Guérin
- (2016) Ashish M. Kamat et al. EUROPEAN UROLOGY
- Economic Burden of Bladder Cancer Across the European Union
- (2016) Jose Leal et al. EUROPEAN UROLOGY
- Biomarkers for precision medicine in bladder cancer
- (2016) Takahiro Kojima et al. International Journal of Clinical Oncology
- Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline
- (2016) Sam S. Chang et al. JOURNAL OF UROLOGY
- Current Status of Urinary Biomarkers for Detection and Surveillance of Bladder Cancer
- (2016) Aurélie Mbeutcha et al. UROLOGIC CLINICS OF NORTH AMERICA
- Prognostic value of urinary cytology and other biomarkers for recurrence and progression in bladder cancer: a prospective study
- (2016) Michael D. Bell et al. WORLD JOURNAL OF UROLOGY
- Novel fluorescencein situhybridization-based definition of bacille Calmette-Guérin (BCG) failure for use in enhancing recruitment into clinical trials of intravesical therapies
- (2015) Ashish M. Kamat et al. BJU INTERNATIONAL
- Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer
- (2015) Faysal A. Yafi et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urine
- (2015) Leonel Maldonado et al. Oncotarget
- A Panel of Three Markers Hyper- and Hypomethylated in Urine Sediments Accurately Predicts Bladder Cancer Recurrence
- (2014) S.-F. Su et al. CLINICAL CANCER RESEARCH
- The use of urinary nuclear matrix protein 22 (NMP22) as a diagnostic adjunct to urine cytology for monitoring of recurrent bladder cancer-institutional experience and review
- (2014) Binnur Önal et al. DIAGNOSTIC CYTOPATHOLOGY
- Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer
- (2014) G Mowatt et al. HEALTH TECHNOLOGY ASSESSMENT
- The mechanism of action of BCG therapy for bladder cancer—a current perspective
- (2014) Gil Redelman-Sidi et al. Nature Reviews Urology
- Multicenter evaluation of the role of UroVysion FISH assay in surveillance of patients with bladder cancer: does FISH positivity anticipate recurrence?
- (2014) Casey Seideman et al. WORLD JOURNAL OF UROLOGY
- Reflex fluorescencein situhybridization assay for suspicious urinary cytology in patients with bladder cancer with negative surveillance cystoscopy
- (2013) Philip H. Kim et al. BJU INTERNATIONAL
- A 3-Plex Methylation Assay Combined with the FGFR3 Mutation Assay Sensitively Detects Recurrent Bladder Cancer in Voided Urine
- (2013) R. Kandimalla et al. CLINICAL CANCER RESEARCH
- Cost-Effectiveness of Fluorescence In Situ Hybridization in Patients with Atypical Cytology for the Detection of Urothelial Carcinoma
- (2013) Bishoy A. Gayed et al. JOURNAL OF UROLOGY
- Is Urinary Soluble Fas an Independent Predictor of Non-Muscle-Invasive Bladder Cancer? A Prospective Chart Study
- (2013) Huixiang Yang et al. UROLOGIA INTERNATIONALIS
- Clinical performance and utility of a DNA methylation urine test for bladder cancer11This study was funded, in part, by MDxHealth (formerly OncoMethlyome Sciences).
- (2013) Michael R. Abern et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, Diagnosis, and Molecular Markers
- (2012) Ashish M. Kamat et al. EUROPEAN UROLOGY
- In the cystoscopic follow-up of non-muscle-invasive transitional cell carcinoma, NMP-22 works for high grades, but unreliable in low grades and upper urinary tract tumors
- (2012) Enis Coskuner et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Prediction of response to bacillus Calmette-Guérin treatment in non-muscle invasive bladder cancer patients through interleukin-6 and interleukin-10 ratio
- (2012) TOMMASO CAI et al. Experimental and Therapeutic Medicine
- Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma
- (2011) Jamie Messer et al. BJU INTERNATIONAL
- Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology
- (2011) Shahrokh F. Shariat et al. CANCER
- Urine Markers for Detection and Surveillance of Non–Muscle-Invasive Bladder Cancer
- (2011) Derya Tilki et al. EUROPEAN UROLOGY
- Immunocytology Is a Strong Predictor of Bladder Cancer Presence in Patients With Painless Hematuria: A Multicentre Study
- (2011) Eugene K. Cha et al. EUROPEAN UROLOGY
- Multicolor FISH (UroVysion) Facilitates Follow-up of Patients With High-Grade Urothelial Carcinoma of the Bladder
- (2010) Hans-Martin Fritsche et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Prediction and diagnosis of bladder cancer recurrence based on urinary content of hTERT, SENP1, PPP1CA, and MCM5 transcripts
- (2010) Anne Sofie Brems-Eskildsen et al. BMC CANCER
- Fibroblast Growth Factor Receptor 3 Mutation Analysis on Voided Urine for Surveillance of Patients with Low-Grade Non-Muscle-Invasive Bladder Cancer
- (2010) T. C. M. Zuiverloon et al. CLINICAL CANCER RESEARCH
- Statistical consideration for clinical biomarker research in bladder cancer
- (2010) Shahrokh F. Shariat et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Considerations on implementing diagnostic markers into clinical decision making in bladder cancer
- (2010) Yair Lotan et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Role of fluorescence in situ hybridization in bladder cancer surveillance of patients with negative cytology
- (2010) Ramy F. Youssef et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Use of the NMP22 BladderChek Test in the Diagnosis and Follow-Up of Urothelial Cancer: A Cross-sectional Study
- (2010) Eu Chang Hwang et al. UROLOGY
- Comparison of ImmunoCyt, UroVysion, and urine cytology in detection of recurrent urothelial carcinoma
- (2009) Peggy S. Sullivan et al. CANCER CYTOPATHOLOGY
- Predictive Value of Urinary Interleukin-8 Cutoff Point for Recurrences After Transurethral Resection Plus Induction Bacillus Calmette-Guérin Treatment in Non–Muscle-Invasive Bladder Tumors
- (2009) Levent Sagnak et al. Clinical Genitourinary Cancer
- HYAL-1 Hyaluronidase: A Potential Prognostic Indicator for Progression to Muscle Invasion and Recurrence in Bladder Cancer
- (2009) Mario W. Kramer et al. EUROPEAN UROLOGY
- The prognostic value of cytology and fluorescencein situhybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guérin therapy
- (2009) Spasenija Savic et al. INTERNATIONAL JOURNAL OF CANCER
- Prospective Validation of the Clinical Usefulness of Reflex Fluorescence In Situ Hybridization Assay in Patients With Atypical Cytology for the Detection of Urothelial Carcinoma of the Bladder
- (2009) Bruce J. Schlomer et al. JOURNAL OF UROLOGY
- Combinations of urine-based tumour markers in bladder cancer surveillance
- (2009) Marcus Horstmann et al. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY
- Nuclear Matrix Protein 22 as Adjunct to Urine Cytology and Cystoscopy in Follow-up of Superficial TCC of Urinary Bladder
- (2009) Narmada P. Gupta et al. UROLOGY
- Economic aspects of bladder cancer: what are the benefits and costs?
- (2009) K. D. Sievert et al. WORLD JOURNAL OF UROLOGY
- The clinical utility of atypical cytology is significantly increased in both screening and monitoring for bladder cancer when indexed with nuclear matrix protein-22
- (2008) Rupesh Raina et al. BJU INTERNATIONAL
- Microsatellite Analysis of Voided-Urine Samples for Surveillance of Low-Grade Non-Muscle-Invasive Urothelial Carcinoma: Feasibility and Clinical Utility in a Prospective Multicenter Study (Cost-Effectiveness of Follow-Up of Urinary Bladder Cancer Trial [CEFUB])
- (2008) Madelon N.M. van der Aa et al. EUROPEAN UROLOGY
- The Molecular Signature for Urothelial Carcinoma of the Upper Urinary Tract
- (2008) Chung-Liang Ho et al. JOURNAL OF UROLOGY
- Prospective Evaluation of the Clinical Usefulness of Reflex Fluorescence In Situ Hybridization Assay in Patients With Atypical Cytology for the Detection of Urothelial Carcinoma of the Bladder
- (2008) Yair Lotan et al. JOURNAL OF UROLOGY
- Urinary Cytology and Quantitative BTA and UBC Tests in Surveillance of Patients with pTapT1 Bladder Urothelial Carcinoma
- (2008) M. Babjuk et al. UROLOGY
- The role of BTA stat Test in follow-up of patients with bladder cancer: results from FinnBladder studies
- (2008) Mika-P. Raitanen et al. WORLD JOURNAL OF UROLOGY
- The Value of the UroVysion® Assay for Surveillance of Non–Muscle-Invasive Bladder Cancer
- (2007) Sigurdur Gudjónsson et al. EUROPEAN UROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More